Alexion Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Large Cap Biopharmaceutical Companies-Metrics And Valuations…
Article By: Rod Raynovich
Wednesday, February 12, 2020 1:00 AM EST
The IBB is at $122.69 near the 52 week high but short of 5 year high of $132.53 from Jy ’15.
In this article: BMY, MRK, RHHBY, ABBV, CELG, IBB, VRTX, ALXN, BIIB, XLV
Read
Biotech (Top Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Friday, January 31, 2020 4:20 PM EST
The cumulative 2020 earnings power of these 30 stocks was revised UP by 2.06% in the past 60 days.
In this article: SNY, ACAD, ALXN, ILMN, INCY, AMGN, BIIB, GILD, GH, BBIO, IBB
Read
IBB Is Positioned For Outperformance
Article By: Andres Cardenal
Friday, December 6, 2019 8:33 AM EST
iShares Nasdaq Biotechnology ETF is benefitting from reduced regulatory risk in the middle term. The ETF is still trading below its highs of 2015, so it has a lot of ground to recover going forward.
In this article: IBB Also: ALXN, ILMN, INCY, REGN, SGEN, AMGN, BIIB, GILD, VRTX
Read
Healthcare & Biotechs Struggle, But Opportunity Ahead
Article By: Tarun Chandra, CFA
Wednesday, October 23, 2019 2:24 AM EST
Improving risk appetite is nudging markets higher, and biotechs will participate as well, although gains will have a ceiling.
In this article: ACAD, ARQL, MNTA, SGEN, MDCO, ARWR, KPTI, RDUS, FLXN, RETA, ZYME, DRNA, TCDA, DCPH, APLS, ACHN, ALXN, VRTX, ALDR, RARX, DOVA
Read
May Employment Report Preview
Article By: Bespoke Investment Group
Thursday, June 6, 2019 12:48 PM EST
Heading into tomorrow’s report, economists are expecting an increase in payrolls of 180K, which would be a sizable decline from April’s much stronger than expected reading of 263K.
In this article: MAT, ALXN, NFLX, NWL, MNK, WDC, DE, PCG, FTR, TRIP
Read

PARTNER HEADLINES

Latest Tweets for $ALXN

No tweets yet!